MARKET

CDTTW

CDTTW

CDT Equity Inc,
NASDAQ
0.0076
+0.0001
+1.33%
Closed 15:31 03/27 EDT
OPEN
0.0076
PREV CLOSE
0.0075
HIGH
0.0079
LOW
0.0076
VOLUME
6.60K
TURNOVER
0
52 WEEK HIGH
0.0217
52 WEEK LOW
0.0050
MARKET CAP
--
P/E (TTM)
0.0000
1D
5D
1M
3M
1Y
5Y
1D
NASDAQ TRADE HALT CONTINUES <CDT.O> VOLATILITY TRADING PAUSE AT 09:30 AM
Reuters · 2d ago
NASDAQ TRADE HALT <CDT.O> HALT NEWS PENDING AT 07:50 PM
Reuters · 3d ago
CDT Equity files two tapinarof patent applications; Organon acquisition of Dermavant totals $1.2 billion
Reuters · 3d ago
CDT EQUITY INC - FILES TWO NEW PATENT APPLICATIONS FOR TAPINAROF
Reuters · 3d ago
CDT Equity files two tapinarof patent applications; IP portfolio expands due to combination therapy and cocrystal claims
Reuters · 3d ago
CDT Equity approves 1-for-25 reverse stock split; consolidation effective March 26, 2026
Reuters · 4d ago
CDT EQUITY INC - BOARD APPROVES 1-FOR-25 REVERSE STOCK SPLIT
Reuters · 4d ago
CDT Equity plans targeted preclinical validation studies to support early-stage out-licensing in rare diseases
Reuters · 6d ago
More
About CDTTW
Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company’s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto’s Thyroiditis. The Company’s asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. It is used as a treatment option for Hashimoto’s Thyroiditis (HT and Graves’ disease, including investigating any negative side effects of the use of AZD1656 as compared with treatment options for Hashimoto’s Thyroiditis and Graves’ disease. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), that has the potential to treat Idiopathic Male Infertility (IMI).

Webull offers Conduit Pharmaceuticals Inc stock information, including NASDAQ: CDTTW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDTTW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDTTW stock methods without spending real money on the virtual paper trading platform.